Immunohematology Global Market Opportunities And Strategies To 2034

Immunohematology Market 2025 – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Emt), Gel Cards, Microplates, Polymerase Chain Reaction (PCR), Other Technologies), By Disease (Blood-Related Diseases, HIV (Human Immunodeficiency Viruses), Hepatitis), By Application (Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology), By End User (Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes), And By Region, Opportunities And Strategies – Global Forecast To 2035

Immunohematology Global Market Opportunities And Strategies To 2034

Report Price : $4490.00 | Pages : 282 | Published : March 2025 | | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN

Immunohematology Market Definition

Immunohematology refers to the branch of medicine and diagnostics that focuses on the study of blood group antigens and antibodies to ensure safe and effective blood transfusion and management of immune-mediated blood disorders. This field encompasses a range of diagnostic methods, devices and reagents used to analyze and identify blood types, detect antibodies and manage conditions related to the immune response involving blood cells.

The immunohematology market consists of sales, by entities (organizations, sole traders, or partnerships), of immunohematology that are utilized primarily when blood compatibility needs to be ensured, such as during pretransfusion testing, organ transplantation and investigation of immune-mediated hemolysis.

Immunohematology Market Size

The global immunohematology market reached a value of nearly $2,458.66 million in 2024, having grown at a compound annual growth rate (CAGR) of 3.24% since 2019. The market is expected to grow from $2,458.66 million in 2024 to $3,174.15 million in 2029 at a rate of 5.24%. The market is then expected to grow at a CAGR of 4.83% from 2029 and reach $4,108.45 million in 2034.  

Growth in the historic period resulted from the increasing prevalence of blood disorders, increase in infectious diseases, expanding healthcare expenditure, rise in trauma and accident cases and favorable government initiative and funding. Factors that negatively affected growth in the historic period were lack of skilled personnel.

Going forward, increasing organ transplants and surgeries, emergence of personalized medicine, growing aging population and strong economic growth will drive the growth. Factor that could hinder the growth of the immunohematology market in the future include limited blood supply.  

Immunohematology Market Drivers

The key drivers of the immunohematology market include:

Increasing Organ Transplants and Surgeries

Increasing organ transplants and surgeries is expected to be a key driver of the growth of the immunohematology market in the forecast period. The increasing prevalence of organ transplants has driven a heightened demand for rigorous blood typing and crossmatching to ensure donor-recipient compatibility. Immunohematology plays a critical role in this process by preventing immune rejection of transplanted organs. As the volume of organ transplants continues to grow, the demand for immunohematology testing has correspondingly increased, presenting significant opportunities for growth in this sector. For instance, in January 2023, the United Network for Organ Sharing, a US-based non-profit scientific and educational organization, reported that 42,887 organ transplants were performed in the United States in 2022, marking a 3.7 percent increase from 2021 and setting a new annual record.  Furthermore, in April 2022, according to the National Library of Medicine, a US-based biomedical library, globally, 2.6 million people undergo renal replacement therapy, including dialysis or kidney transplants, a number that is projected to double by 2030. Therefore, the increasing number of organ transplants and surgeries will drive demand for immunohematology going forward.

Immunohematology Market Restraints

The key restraints on the immunohematology market include:

Limited Blood Supply

The limited blood supply is expected to limit the growth of the immunohematology market in the forecast period. Immunohematology depends on a reliable and sufficient supply of donated blood for both testing and transfusion purposes. Insufficient donation rates can result in shortages, impairing the ability to conduct essential diagnostic procedures such as blood typing, antibody screening and crossmatching. For instance, in May 2024, according to the report Journal of Korean Medical Science published by the Korean Academy of Medical Sciences, a South Korea-based organization dedicated to advancing medical science and research, the blood supply is projected to decline from 2.6 million units in 2021 to 1.4 million units by 2050. Therefore, limited blood supply may hinder the growth of the immunohematology market.

Immunohematology Market Trends

Major trends shaping the immunohematology market include:

Next-Generation Blood Processing System With Cutting-Edge Automation

Major companies operating in the immunohematology market are focusing on developing next-generation blood processing systems with cutting-edge automation. The system enhances blood supply management by automating the process of separating whole blood into its components, making blood processing faster, more reliable and more efficient, which ultimately benefits hospitals and patients in need of blood transfusions. For instance, in October 2024, Terumo Blood and Cell Technologies, a US-based provider of blood management solutions, launched the Reveos Automated Blood Processing System in the United States, in partnership with Blood Centers of America, a US-based cooperative representing community blood centers. This cutting-edge system is engineered to streamline blood processing by automating the separation of whole blood into its components, such as platelets, plasma and red blood cells—within a single centrifugation cycle. These components are vital in transfusion medicine. The first deployment of the system will take place at Carter BloodCare in Texas, to enhance blood supply management and optimize operational efficiency across blood centers nationwide.

Optimizing Blood Testing Processes With Advanced Multiplex Analysis

Companies operating in the immunohematology market focus on transforming blood transfusion management with advanced multiplex analysis. This technology enables high-resolution analysis of blood samples, allowing for more comprehensive and accurate results while reducing the need for multiple individual tests. It optimizes the testing process by grouping various parameters in one step, improving the efficiency and throughput of blood testing. For instance, in June 2024, Innobiochips, a France-based biotechnology company, introduced Omnys, an advanced solution designed to optimize blood transfusion, grouping and testing processes. This innovative system significantly improves laboratory efficiency by enabling multiplex analysis with high-resolution testing of blood components, such as ABO (major blood group system) /D typing (Rh factor) and phenotyping, while reducing the number of wells required from 16 to just 4-6. The Omnys incorporates multiple patented technologies, streamlining operations, minimizing waste and reducing the carbon footprint associated with blood testing. A beta testing program for Omnys is scheduled to begin in early 2025, offering blood banks and healthcare institutions an opportunity to assess its integration into transfusion workflows.

Opportunities And Recommendations In The Immunohematology Market

Opportunities – The top opportunities in the immunohematology markets segmented by product will arise in the reagents segment, which will gain $407.42 million of global annual sales by 2029. The top opportunities in the immunohematology market segmented by technology will arise in the polymerase chain reaction (PCR) segment, which will gain $310.72 million of global annual sales by 2029. The top opportunities in the immunohematology markets segmented by disease will arise in the blood-related diseases segment, which will gain $477.18 million of global annual sales by 2029. The top opportunities in the immunohematology markets segmented by application will arise in the pretransfusion testing segment, which will gain $324.77 million of global annual sales by 2029. The top opportunities in the immunohematology markets segmented by end user will arise in the hospitals segment, which will gain $306.08 million of global annual sales by 2029. The immunohematology market size will gain the most in USA at $241.59 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the immunohematology companies to focus on developing next-generation blood processing systems, focus on advancing multiplex blood testing technology, focus on the fastest-growing analyzers and systems segment, focus on biochips for accelerated growth, focus on blood-related diseases for market expansion, focus on pretransfusion testing to drive growth, expand in emerging markets, focus on expanding distribution channels for market growth, focus on developing competitive and value-based pricing strategies, focus on digital marketing strategies to enhance brand authority for immunohematology companies, focus on strategic partnerships with key opinion leaders to build credibility for immunohematology companies and focus on hospitals to drive growth in the immunohematology market.

Immunohematology Market Segmentation

The immunohematology market is segmented by product, by technology, by disease, by application and by end user.


By Product –


The immunohematology market is segmented by product into:

    • a) Analyzers And Systems
    • b) Reagents

The reagents market was the largest segment of the immunohematology market segmented by product, accounting for 59.02% or $1,451.22 million of the total in 2024. Going forward, the analyzers and systems segment is expected to be the fastest growing segment in the immunohematology market segmented by product, at a CAGR of 5.48% during 2024-2029.


By Technology –


The immunohematology market is segmented by technology into:

    • a) Biochips
    • b) Erythrocyte-Magnetized Technology (Emt)
    • c) Gel Cards
    • d) Microplates
    • e) Polymerase Chain Reaction (PCR)
    • f) Other Technologies

The polymerase chain reaction (PCR) market was the largest segment of the immunohematology market segmented by technology, accounting for 32.91% or 809.03 million of the total in 2024. Going forward, the biochips segment is expected to be the fastest growing segment in the immunohematology market segmented by technology, at a CAGR of 7.21% during 2024-2029.


By Disease –


The immunohematology market is segmented by disease into:

    • a) Blood-Related Diseases
    • b) HIV (Human Immunodeficiency Viruses)
    • c) Hepatitis

The blood-related diseases market was the largest segment of the immunohematology market segmented by disease, accounting for 59.73% or $1,468.58 million of the total in 2024. Going forward, the blood-related diseases segment is expected to be the fastest growing segment in the immunohematology market segmented by disease, at a CAGR of 5.79% during 2024-2029.


By Application –


The immunohematology market is segmented by application into:

    • a) Pretransfusion Testing
    • b) Investigation Of Immune Hemolysis
    • c) Perinatal Testing
    • d) Blood Group Phenotyping
    • e) Leucocyte And Platelet Serology

The pretransfusion market was the largest segment of the immunohematology market segmented by application, accounting for 40.81% or $1,003.29 million of the total in 2024. Going forward, the pretransfusion testing segment is expected to be the fastest growing segment in the immunohematology market segmented by application, at a CAGR of 5.77% during 2024-2029.


By End User –


The immunohematology market is segmented by end user into:

    • a) Blood Banks
    • b) Diagnostic And Reference Laboratories
    • c) Hospitals
    • d) Academic And Research Institutes

The hospitals market was the largest segment of the immunohematology market segmented by end user, accounting for 39.21% or $963.94 million of the total in 2024. Going forward, the hospitals segment is expected to be the fastest growing segment in the immunohematology market segmented by end user, at a CAGR of 5.67% during 2024-2029.


By Geography - The immunohematology market is segmented by geography into:

      o Asia Pacific

      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea

      o North America

      • • USA
      • • Canada

      o South America

      • • Brazil

      o Western Europe

      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain

      o Eastern Europe

      • • Russia

      o Middle East

      o Africa

North America was the largest region in the immunohematology market, accounting for 39.72% or $976.68 million of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the immunohematology market will be Asia Pacific and Western Europe where growth will be at CAGRs of5.69% and 5.43% respectively. These will be followed by North America and South America where the markets are expected to grow at CAGRs of 5.31% and 4.93% respectively.

Immunohematology Market Competitive Landscape

Major Competitors are:

  • QuidelOrtho Corporation (Ortho-Clinical Diagnostics)
  • Abbott Laboratories
  • Grifols S.A.
  • BIO-RAD LABORATORIES, INC.
  • Beckman Coulter Inc. (Danaher Corporation)
  • Other Competitors Include:

  • BECTON, DICKINSON AND COMPANY
  • Cardinal Health Inc.
  • Siemens Healthineers
  • F. Hoffmann-La Roche AG
  • Sysmex Corporation
  • Immucor Inc.
  • Thermo Fisher Scientific
  • Merck KGaA
  • Nihon Kohden Corporation
  • Hologic, Inc.
  • MTC Invitro Diagnostics AG
  • Terumo Blood and Cell Technologies (Terumo BCT)
  • bioMérieux SA
  • EUROIMMUN
  • Roche Diagnostics
  • Unilabs
  • Medsol diagnostics
  • Me Cure Healthcare Ltd.
    1. Table Of Contents

      1 Executive Summary

      1.1 Immunohematology – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 Immunohematology Market Definition And Segmentations

      6.4 Market Segmentation By Product

      6.4.1 Analyzers And Systems

      6.4.2 Reagents

      6.5 Market Segmentation By Technology

      6.5.1 Biochips

      6.5.2 Erythrocyte-Magnetized Technology (Emt)

      6.5.3 Gel Cards

      6.5.4 Microplates

      6.5.5 Polymerase Chain Reaction (PCR)

      6.5.6 Other Technologies

      6.6 Market Segmentation By Disease

      6.6.1 Blood-Related Diseases

      6.6.2 HIV (Human immunodeficiency viruses)

      6.6.3 Hepatitis

      6.7 Market Segmentation By Application

      6.7.1 Pretransfusion Testing

      6.7.2 Investigation Of Immune Hemolysis

      6.7.3 Perinatal Testing

      6.7.4 Blood Group Phenotyping

      6.7.5 Leucocyte And Platelet Serology

      6.8 Market Segmentation By End User

      6.8.1 Blood Banks

      6.8.2 Diagnostic And Reference Laboratories

      6.8.3 Hospitals

      6.8.4 Academic And Research Institutes

      7 Major Market Trends

      7.1 Next-Generation Blood Processing System With Cutting-Edge Automation

      7.2 Optimizing Blood Testing Processes With Advanced Multiplex Analysis

      8 Immunohematology Market - Macro Economic Scenario

      8.1 COVID-19 Impact On The Immunohematology Market

      8.2 Impact Of The War In Ukraine On The Immunohematology Market

      8.3 Impact Of High Inflation On The Immunohematology Market

      9 Global Market Size and Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2019 – 2024, Value ($ Million)

      9.2.1 Market Drivers 2019 – 2024

      9.2.2 Market Restraints 2019– 2024

      9.3 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)

      9.3.1 Market Drivers 2024 – 2029

      9.3.2 Market Restraints 2024 – 2029

      10 Global Immunohematology Market Segmentation

      10.1 Global Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.2 Global Immunohematology Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.3 Global Immunohematology Market, Segmentation By Disease, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.4 Global Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.5 Global Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11 Immunohematology Market, Regional and Country Analysis

      11.1 Global Immunohematology Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.2 Global Immunohematology Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.1.1 Market Overview

      12.1.2 Region Information

      12.1.3 Market Information

      12.1.4 Background Information

      12.1.5 Government Initiatives

      12.1.6 Regulations

      12.1.7 Regulatory Bodies

      12.1.8 Major Associations

      12.1.9 Taxes Levied

      12.1.10 Corporate Tax Structure

      12.1.11 Investments

      12.1.12 Major Companies

      12.2 Asia-Pacific Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.3 Asia-Pacific Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.4 Asia-Pacific Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.5 Asia-Pacific Immunohematology Market: Country Analysis

      12.6 China Market

      12.7 Summary

      12.7.1 Market Overview

      12.7.2 Country Information

      12.7.3 Market Information

      12.7.4 Background Information

      12.7.5 Government Initiatives

      12.7.6 Regulations

      12.7.7 Regulatory Bodies

      12.7.8 Major Associations

      12.7.9 Taxes Levied

      12.7.10 Corporate Tax Structure

      12.7.11 Investments

      12.7.12 Major Companies

      12.8 China Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.9 China Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.10 China Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.11 India Market

      12.12 India Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.13 India Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.14 India Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.15 Japan Market

      12.16 Japan Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.17 Japan Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.18 Japan Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.19 Australia Market

      12.20 Australia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.21 Australia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.22 Australia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.23 Indonesia Market

      12.24 Indonesia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.25 Indonesia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.26 Indonesia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.27 South Korea Market

      12.28 South Korea Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.29 South Korea Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.30 South Korea Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.1.1 Market Overview

      13.1.2 Region Information

      13.1.3 Market Information

      13.1.4 Background Information

      13.1.5 Government Initiatives

      13.1.6 Regulations

      13.1.7 Regulatory Bodies

      13.1.8 Major Associations

      13.1.9 Taxes Levied

      13.1.10 Corporate tax structure

      13.1.11 Investments

      13.1.12 Major Companies

      13.2 Western Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.3 Western Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.4 Western Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.5 Western Europe Immunohematology Market: Country Analysis

      13.6 UK Market

      13.7 UK Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.8 UK Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.9 UK Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.10 Germany Market

      13.11 Germany Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.12 Germany Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.13 Germany Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.14 France Market

      13.15 France Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.16 France Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.17 France Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.18 Italy Market

      13.19 Italy Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.20 Italy Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.21 Italy Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.22 Spain Market

      13.23 Spain Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.24 Spain Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.25 Spain Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.1.1 Market Overview

      14.1.2 Region Information

      14.1.3 Market Information

      14.1.4 Background Information

      14.1.5 Government Initiatives

      14.1.6 Regulations

      14.1.7 Regulatory Bodies

      14.1.8 Major Associations

      14.1.9 Taxes Levied

      14.1.10 Corporate Tax Structure

      14.1.11 Major companies

      14.2 Eastern Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.3 Eastern Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.4 Eastern Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.5 Eastern Europe Immunohematology Market: Country Analysis

      14.6 Russia Market

      14.7 Russia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.8 Russia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.9 Russia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.1.1 Market Overview

      15.1.2 Region Information

      15.1.3 Market Information

      15.1.4 Background Information

      15.1.5 Government Initiatives

      15.1.6 Regulations

      15.1.7 Regulatory Bodies

      15.1.8 Major Associations

      15.1.9 Taxes Levied

      15.1.10 Corporate Tax Structure

      15.1.11 Investments

      15.1.12 Major Companies

      15.2 North America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.3 North America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.4 North America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.5 North America Immunohematology Market: Country Analysis

      15.6 USA Market

      15.7 Summary

      15.7.1 Market Overview

      15.7.2 Country Information

      15.7.3 Market Information

      15.7.4 Background Information

      15.7.5 Government Initiatives

      15.7.6 Regulations

      15.7.7 Regulatory Bodies

      15.7.8 Major Associations

      15.7.9 Taxes Levied

      15.7.10 Corporate Tax Structure

      15.7.11 Investments

      15.7.12 Major Companies

      15.8 USA Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.9 USA Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.10 USA Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.11 Canada Market

      15.12 Canada Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.13 Canada Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.14 Canada Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.1.1 Market Overview

      16.1.2 Region Information

      16.1.3 Market Information

      16.1.4 Background Information

      16.1.5 Government Initiatives

      16.1.6 Regulations

      16.1.7 Regulatory Bodies

      16.1.8 Major Associations

      16.1.9 Taxes Levied

      16.1.10 Corporate Tax Structure

      16.1.11 Investments

      16.1.12 Major Companies

      16.2 South America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.3 South America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.4 South America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.5 South America Immunohematology Market: Country Analysis

      16.6 Brazil Market

      16.7 Brazil Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.8 Brazil Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.9 Brazil Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.1.1 Market Overview

      17.1.2 Region Information

      17.1.3 Market Information

      17.1.4 Background Information

      17.1.5 Government Initiatives

      17.1.6 Regulations

      17.1.7 Regulatory Bodies

      17.1.8 Major Associations

      17.1.9 Taxes Levied

      17.1.10 Corporate Tax Structure

      17.1.11 Major Companies

      17.2 Middle East Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.3 Middle East Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.4 Middle East Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.1.1 Market Overview

      18.1.2 Region Information

      18.1.3 Market Information

      18.1.4 Background Information

      18.1.5 Government Initiatives

      18.1.6 Regulations

      18.1.7 Regulatory Bodies

      18.1.8 Major Associations

      18.1.9 Taxes Levied

      18.1.10 Corporate Tax Structure

      18.1.11 Investments

      18.1.12 Major Companies

      18.2 Africa Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      18.3 Africa Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      18.4 Africa Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      19 Competitive Landscape And Company Profiles

      19.1 Company Profiles

      19.2 QuidelOrtho Corporation

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Business Strategy

      19.2.4 Financial Overview

      19.3 Abbott Laboratories

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Financial Overview

      19.4 Grifols S.A.

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial Overview

      19.5 Bio-Rad Laboratories, Inc

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Business Strategy

      19.5.4 Financial Overview

      19.6 Danaher Corporation (Beckman Coulter, Inc.)

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Financial Overview

      20 Competitive Benchmarking

      21 Competitive Dashboard

      22 Key Mergers And Acquisitions

      22.1 Werfen S.A. Acquired Immucor, Inc. to Strengthen Specialized Diagnostics Portfolio

      22.2 Quidel Corporation And Ortho Clinical Diagnostics Merger Strengthens Global In Vitro Diagnostics Leadership

      23 Opportunities And Strategies

      23.1 Global Immunohematology Market In 2029 – Countries Offering Most New Opportunities

      23.2 Global Immunohematology Market In 2029 – Segments Offering Most New Opportunities

      23.3 Global Immunohematology Market In 2029 – Growth Strategies

      23.3.1 Market Trend Based Strategies

      23.3.2 Competitor Strategies

      24 Immunohematology Market, Conclusions And Recommendations

      24.1 Conclusions

      24.2 Recommendations

      24.2.1 Product

      24.2.2 Place

      24.2.3 Price

      24.2.4 Promotion

      24.2.5 People

      25 Appendix

      25.1 Geographies Covered

      25.2 Market Data Sources

      25.3 Research Methodology

      25.4 Currencies

      25.5 The Business Research Company

      25.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global Immunohematology Market, Historic, 2019 – 2024, $ Million
    • Table 2: Global Immunohematology Market, Forecast, 2024 – 2029, 2034F , $ Million
    • Table 3: Global Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 4: Global Immunohematology Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 5: Global Immunohematology Market, Segmentation By Disease, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 6: Global Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 7: Global Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 8: Global Immunohematology Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 9: Global Immunohematology Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 10: Asia-Pacific GDP Per Capita, By Country, 2019-2024, $
    • Table 11:  Asia-Pacific Population, By Country, 2019-2029, Millions
    • Table 12: Asia-Pacific Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 13: Asia-Pacific Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 14: Asia-Pacific Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 15: China GDP Per Capita, 2019-2024, $
    • Table 16:  China Population, 2019-2029, Millions
    • Table 17: China Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 18: China Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 19: China Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 20: India Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 21: India Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 22: India Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 23: Japan Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 24: Japan Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 25: Japan Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 26: Australia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 27: Australia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 28: Australia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 29: Indonesia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 30: Indonesia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 31: Indonesia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 32: South Korea Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 33: South Korea Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 34: South Korea Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 35: Western Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 36:  Western Europe Population, By Country, 2019-2029, Millions
    • Table 37: Western Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 38: Western Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 39: Western Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 40: UK Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 41: UK Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 42: UK Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 43: Germany Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 44: Germany Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 45: Germany Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 46: France Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 47: France Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 48: France Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 49: Italy Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 50: Italy Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 51: Italy Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 52: Spain Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 53: Spain Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 54: Spain Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 55: Eastern Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 56:  Eastern Europe Population, By Country, 2019-2029, Millions
    • Table 57: Eastern Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 58: Eastern Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 59: Eastern Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 60: Russia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 61: Russia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 62: Russia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 63: North America GDP Per Capita, By Country, 2019-2024, $
    • Table 64:  North America Population, By Country, 2019-2029, Millions
    • Table 65: North America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 66: North America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 67: North America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 68: USA GDP Per Capita, 2019-2024, $
    • Table 69:  USA Population, 2019-2029, Millions
    • Table 70: USA Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 71: USA Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 72: USA Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 73: Canada Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 74: Canada Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 75: Canada Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 76: South America GDP Per Capita, By Country, 2019-2024, $
    • Table 77:  South America Population, By Country, 2019-2029, Millions
    • Table 78: South America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 79: South America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 80: South America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 81: Brazil Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 82: Brazil Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 83: Brazil Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 84: Middle East GDP Per Capita, By Country, 2019-2024, $
    • Table 85:  Middle East Population, By Country, 2019-2029, Millions
    • Table 86: Middle East Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 87: Middle East Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 88: Middle East Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 89: Africa GDP Per Capita, By Country, 2019-2024, $
    • Table 90:  Africa Population, By Country, 2019-2029, Millions
    • Table 91: Africa Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 92: Africa Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 93: Africa Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 94: Global Immunohematology Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Table 95: QuidelOrtho Corporation – Financial Overview, 2019 – 2023, $ Billion
    • Table 96: Abbott Laboratories – Financial Overview, 2019 – 2023, $Billion
    • Table 97: Grifols S.A. – Financial Overview, 2019 – 2023, $ Billion
    • Table 98: Bio-Rad Laboratories, Inc – Financial Overview, 2019 – 2023, $ Billion
    • Table 99: Danaher Corporation – Financial Overview, 2019 – 2023, $Billion
    • Table 100: Immunohematology Market, Competitive Benchmarking (In USD Millions)
    • Table 101: Immunohematology Market, Competitive Dashboard
    • Table 102: Global Immunohematology Market Size Gain ($ Million), 2024 – 2029, By Country
    • Table 103: Global Immunohematology Market Size Gain ($ Million), Segmentation By Product, 2024 – 2029
    • Table 104: Global Immunohematology Market Size Gain ($ Million), Segmentation By Technology, 2024 – 2029
    • Table 105: Global Immunohematology Market Size Gain ($ Million), Segmentation By Disease, 2024 – 2029
    • Table 106: Global Immunohematology Market Size Gain ($ Million), Segmentation By Application, 2024 – 2029
    • Table 107: Global Immunohematology Market Size Gain ($ Million), Segmentation By End User, 2024 – 2029
    • Table 108: Immunohematology Market Data Sources

    List Of Figures

      Figure 1: Global Immunohematology Market Segmentation By Product
    • Figure 2: Global Immunohematology Market Segmentation By Technology
    • Figure 3: Global Immunohematology Market Segmentation By Disease
    • Figure 4: Global Immunohematology Market Segmentation By Application
    • Figure 5: Global Immunohematology Market Segmentation By End User
    • Figure 6: Global Immunohematology Market, Historic, 2019 – 2024, $ Million
    • Figure 7: Global Immunohematology Market, Forecast, 2024 – 2029, 2034F, $ Million
    • Figure 8: Global Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 9: Global Immunohematology Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 10: Global Immunohematology Market, Segmentation By Disease, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 11: Global Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 12: Global Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 13: Global Immunohematology Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 14: Global Immunohematology Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 15: Asia-Pacific Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 16: Asia-Pacific Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 17: Asia-Pacific Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 18: China Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 19: China Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 20: China Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 21: India Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 22: India Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 23: India Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 24: Japan Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 25: Japan Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 26: Japan Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 27: Australia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 28: Australia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 29: Australia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 30: Indonesia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 31: Indonesia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 32: Indonesia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 33: South Korea Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 34: South Korea Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 35: South Korea Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 36: Western Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 37: Western Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 38: Western Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 39: UK Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 40: UK Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 41: UK Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 42: Germany Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 43: Germany Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 44: Germany Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 45: France Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 46: France Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 47: France Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 48: Italy Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 49: Italy Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 50: Italy Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 51: Spain Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 52: Spain Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 53: Spain Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 54: Eastern Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 55: Eastern Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 56: Eastern Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 57: Russia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 58: Russia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 59: Russia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 60: North America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 61: North America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 62: North America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 63: USA Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 64: USA Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 65: USA Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 66: Canada Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 67: Canada Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 68: Canada Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 69: South America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 70: South America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 71: South America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 72: Brazil Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 73: Brazil Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 74: Brazil Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 75: Middle East Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 76: Middle East Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 77: Middle East Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 78: Africa Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 79: Africa Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 80: Africa Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 81: Global Immunohematology Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Figure 82: QuidelOrtho Corporation – Financial Overview, 2019 – 2023, $ Billion
    • Figure 83: Abbott Laboratories – Financial Overview, 2019 – 2023, $ Billion
    • Figure 84: Grifols S.A. – Financial Overview, 2019 – 2023, $ Billion
    • Figure 85: Bio-Rad Laboratories, Inc – Financial Overview, 2019 – 2023, $ Billion
    • Figure 86: Danaher Corporation – Financial Overview, 2019 – 2023, $ Billion
    • Figure 87: Geographic Regions Covered
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report